Kim Perkins

Kim Perkins has extensive work experience in the biopharmaceutical industry. Kim is currently the Director of Nonclinical Operations at Pliant Therapeutics since May 2022. Prior to that, they held the role of Senior Director Nonclinical Operations at Theravance Biopharma US, Inc. from August 2021 to May 2022, and Director Nonclinical Operations from November 2017 to August 2021. Kim also worked at Mateon Therapeutics (formerly OXiGENE) as the Senior Director of Operations from June 2015 to November 2017, and as the Director of Nonclinical Operations from November 2014 to June 2015. Kim Perkins served as a Senior Manager at Theravance from January 2012 to October 2014. Earlier in their career, they held positions at OXiGENE, Inc. as the Director of Preclinical and Project Management from December 2011 to January 2012, and as the Associate Director of Preclinical Development from July 2008 to December 2011. Kim began their career as a Research Associate at Nektar Therapeutics in 1995 and advanced to the position of Scientist from 2005 to July 2008.

From 1991 to 1994, Kim Perkins attended UC Santa Barbara, but there is no information available regarding a degree or field of study.